Pacific Biosciences Of California PACB
NASDAQ PACB
$2.11 -0.13 (-6.03%)
As of: Nov 11, 2026 · 3:47 PM EST

Pacific Biosciences Of California (PACB) Return on Sales [ROS] (2010 - 2026)

Updated

Pacific Biosciences Of California (PACB) recorded Return on Sales [ROS] of -114.36% in Q2 2026, down 1.57 percentage points from -112.79% a year earlier and down 91.89 percentage points from the prior quarter.

Analysis

Pacific Biosciences Of California (PACB) Return on Sales [ROS] (2010 - 2026) Analysis & Trends

On a TTM basis, Pacific Biosciences Of California's Return on Sales [ROS] came in at -83.53% as of Jun 30, 2026, up 359.04 percentage points year-over-year; for FY2025, it came in at -346.15%, down 38.18 percentage points from FY2024.

  • Annual Return on Sales [ROS] has a five-year change of -213.84 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -307.97% in FY2024 (-141.17 pp), -166.80% in FY2023 (+72.63 pp), -239.43% in FY2022 (-78.19 pp) and -161.24% in FY2021 (-28.92 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Sales [ROS] since Q1 2025.
  • On a year-over-year basis, Return on Sales [ROS] rose in four of the last eight quarters, with an average year-over-year change of +83.23 percentage points.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 1132.03 percentage points in Q1 2026, against a drop of 944.87 percentage points in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at -22.48% (Q1 2026), -92.28% (Q4 2025) and -101.13% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn 18.65%
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 10.44%
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn 19.00%
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn 19.44%
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn 18.08%
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn 15.86%
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn 16.12%
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn 17.44%
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 6.36%
10 Pacific Biosciences Of California 699.41 Mn -292.35 Mn 13.47 Mn -91.22%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -91.22%
Jun 30, 2026 -114.36%
Mar 31, 2026 -22.48%
Dec 31, 2025 -92.28%
Sep 30, 2025 -101.13%
Jun 30, 2025 -112.79%
Mar 31, 2025 -1,154.51%
Dec 31, 2024 -390.14%
Sep 30, 2024 -160.32%
Jun 30, 2024 -488.28%
Mar 31, 2024 -209.64%
Dec 31, 2023 -150.02%
Sep 30, 2023 -148.12%
Jun 30, 2023 -153.82%
Mar 31, 2023 -234.58%
Dec 31, 2022 -318.37%
Sep 30, 2022 -230.94%
Jun 30, 2022 -191.64%
Mar 31, 2022 -233.69%
Dec 31, 2021 -179.56%
API Access

Pacific Biosciences Of California Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PACB&period=max&api_key=YOUR_API_KEY